Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) ...

Chronic liver disease poses a growing global health burden, driven in large part by metabolic risk factors and viral hepatitis. Fibrosis stage is the principal ...

Non-invasive biomarkers and scoring systems demonstrated effectiveness in differentiating chronic liver disease (CLD) from cirrhosis; non-invasive fibrosis scores such as the Lok index, King's score, ...

Non-invasive indicators of liver fibrosis could help with risk stratification for heart failure. The median follow-up duration was 10.7 years. For all three measures of liver fibrosis, the risk for ...

Steatotic liver disease (SLD), previously known as non-alcoholic fatty liver disease, which includes a range of conditions caused by fat build-up in the liver due to abnormal lipid metabolism, affects ...

"[We] have conducted a large individual participant data meta-analysis and shown that screening strategies using sequential application of simple NITs like FIB-4 or NFS followed by LSM-VCTE achieve ...

Focused ultrasound creates precise mechanical cavitation that liquefies tumor tissue while sparing adjacent parenchyma, avoiding thermal sink effects and reducing risk near major vessels and bile ...

Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO-a certified algorithm de ...